S-nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 34, 2011, Pages 14330-14335

  Qu, Jing ^a   Nakamura, Tomohiro ^a   Cao, Gang ^a   Holland, Emily A ^a   McKercher, Scott R ^a   Lipton, Stuart A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN DEPENDENT KINASE 5; CYSTEINE; NITRIC OXIDE; THIOL GROUP;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CADAVER; CONTROLLED STUDY; DENDRITIC SPINE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NITROSYLATION; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SYNAPTIC POTENTIAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BRAIN; CYCLIN-DEPENDENT KINASE 5; CYSTEINE; DENDRITIC SPINES; DYNAMINS; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MUTATION; N-METHYLASPARTATE; NITRIC OXIDE; NITROSATION; RATS; SYNAPSES;

EID: 80052150240     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1105172108     Document Type: Article

References (49)

1. Lew J, et al. (1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371: 423-426. (Pubitemid 24302557)
2. Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423. (Pubitemid 24302556)
3. Tang D, et al. (1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 270:26897-26903.
4. Ohshima T, et al. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178. (Pubitemid 26333137)
5. Xie Z, Sanada K, Samuels BA, Shih H, Tsai LH (2003) Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 114:469-482. (Pubitemid 37100995)
6. Kim Y, et al. (2006) Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 442:814-817. (Pubitemid 44258911)
7. Patrick GN, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622. (Pubitemid 129516324)
8. Nguyen MD, Larivière RC, Julien JP (2001) Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-147. (Pubitemid 32441682)
9. Smith PD, et al. (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 100: 13650-13655. (Pubitemid 37444794)
10. Qu D, et al. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55:37-52. (Pubitemid 46990825)
11. Paoletti P, et al. (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: The role of p25/cyclin-dependent kinase 5. J Neurosci 28:10090-10101.
12. Lee MS, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
13. Strocchi P, Pession A, Dozza B (2003) Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells. J Cell Biochem 88:758-765. (Pubitemid 36258825)
14. Zambrano CA, Egaña JT, Núñez MT, Maccioni RB, González-Billault C (2004) Oxidative stress promotes tau dephosphorylation in neuronal cells: The roles of cdk5 and PP1. Free Radic Biol Med 36:1393-1402. (Pubitemid 38596799)
15. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharideinduced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25:8843-8853. (Pubitemid 41384452)
16. Sahlgren CM, et al. (2006) A nestin scaffold links Cdk5/p35 signaling to oxidantinduced cell death. EMBO J 25:4808-4819. (Pubitemid 44607026)
17. Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH (2005) Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48:825-838.
18. Nakamura T, Lipton SA (2008) Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal 10:87-101. (Pubitemid 350115990)
19. Uehara T, et al. (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441:513-517. (Pubitemid 44050153)
20. Cho DH, et al. (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324:102-105.
21. Asada A, et al. (2008) Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J Neurochem 106:1325-1336.
22. Foster MW, Forrester MT, Stamler JS (2009) A protein microarray-based analysis of S-nitrosylation. Proc Natl Acad Sci USA 106:18948-18953.
23. Zhang P, et al. (2010) S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development. J Neurosci 30: 14366-14370.
24. Tian B, Yang Q, Mao Z (2009) Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 11:211-218.
25. Stamler JS, Toone EJ, Lipton SA, Sucher NJ (1997) (S)NO signals: Translocation, regulation, and a consensus motif. Neuron 18:691-696. (Pubitemid 27232781)
26. Marino SM, Gladyshev VN (2010) Structural analysis of cysteine S-nitrosylation: A modified acid-based motif and the emerging role of trans-nitrosylation. J Mol Biol 395:844-859.
27. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH (2001) Protein Snitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193-197. (Pubitemid 32118373)
28. Wang J, Liu S, Fu Y, Wang JH, Lu Y (2003) Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat Neurosci 6:1039-1047. (Pubitemid 37186195)
29. Meijer L, et al. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536. (Pubitemid 27060443)
30. Hawasli AH, et al. (2007) Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci 10:880-886. (Pubitemid 47018172)
31. Tsai LH, Lee MS, Cruz J (2004) Cdk5, a therapeutic target for Alzheimer's disease? Biochim Biophys Acta 1697:137-142.
32. Shankar GM, et al. (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875. (Pubitemid 46438992)
33. Harkany T, et al. (2000) beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12:2735-2745.
34. Xia P, Chen HSV, Zhang D, Lipton SA (2010) Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci 30:11246-11250.
35. Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov 5:160-170.
36. Lue LF, et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-862.
37. McLean CA, et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866.
38. Terry RD, et al. (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
39. Nakamura T, et al. (2010) Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell 39:184-195.
40. Barsoum MJ, et al. (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25:3900-3911. (Pubitemid 44300275)
41. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS (2005) Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6:150-166. (Pubitemid 40215810)
42. Mitchell DA, Marletta MA (2005) Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol 1:154-158.
43. Meuer K, et al. (2007) Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ 14:651-661. (Pubitemid 46444503)
44. Ko J, et al. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771. (Pubitemid 32781119)
45. Mohamed TM, et al. (2009) Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J Biol Chem 284:12091-12098.
46. Minegishi S, et al. (2010) Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39. Biochemistry 49: 5482-5493.
47. Collin C, Miyaguchi K, Segal M (1997) Dendritic spine density and LTP induction in cultured hippocampal slices. J Neurophysiol 77:1614-1623. (Pubitemid 27137052)
48. Fu WY, et al. (2007) Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci 10:67-76.
49. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 336:417-424. (Pubitemid 24036992)